AAV vector expressing anti-aC1s/anti-factor Bb scFabs (Sanofi)

N/A

Report date: 2025/06/11 10:54:14

Base Information

Drug NameAAV vector expressing anti-aC1s/anti-factor Bb scFabs (Sanofi)
Drug Alias NameAAV-aC1sscFab-BbscFab
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionComplement factor B inhibitorsComplement C1s inhibitors
TargetsComplement C1sComplement factor B
Therapy Area/IndicationsGeographic Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesGenzyme Corp
Inactive CompaniesN/A
Active IndicationsGeographic Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A